Biocon Biologics to sell India branded formulations biz to Eris Lifesciences for ₹1,242 cr
The deal will facilitate Eris's entry into the injectables market in India, bringing major insulin brands Basalog and Insugen into the company
citynews
1
The deal will facilitate Eris's entry into the injectables market in India, bringing major insulin brands Basalog and Insugen into the company
